Table of Contents
<< Previous Issue | Dec 2013 (Vol: 2013, Issue: 12) | Next Issue >> |
- Section: Licensing
-
Celgene Targets Cancer Stem Cells with US$3.3 B OncoMed Collaboration
- Section: Mergers & Acquisitions
-
Clovis Expands Portfolio of Targeted Cancer Drugs with EOS Purchase
-
The Medicines Company Steps Up Antibiotics Development with Rempex Purchase
- Section: Research & Development
-
Molecular Partners and Roche Collaborate to Develop Protein-Drug Conjugates in Oncology